(RCKT) |
| 0 (0%) 05-29 15:06 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 3.96 |
| Resistance 1: | 3.54 |
| Pivot price: | 3.21 |
| Support 1: | 2.87 |
| Support 2: | 2.39 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -1.870 |
| Book Value | 2.180 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | -35.1 |
| Return on Equity (ttm) | -64.4 |
Company news
Thu, 28 May 2026
RCKT Stock Price | Betashares Space Industry ETF - Investing.com
Thu, 28 May 2026
Rocket Pharmaceuticals (NASDAQ: RCKT) exchanges options; 686,137 new grants - Stock Titan
Thu, 28 May 2026
Rocket Pharmaceuticals (RCKT) executive swaps underwater options for new $3.00 grants - Stock Titan
Thu, 28 May 2026
Biotech Rocket Pharma CEO joins Jefferies, Goldman investor chats in June - Stock Titan
Tue, 26 May 2026
[Form 4] ROCKET PHARMACEUTICALS, INC. Insider Trading Activity - Stock Titan
Sun, 24 May 2026
JP Morgan Downgrades Rocket Pharmaceuticals (RCKT) - MSN
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
